Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
denosumab (prolia) (1 trial)
lipid emulsion (1 trial)
sitagliptin (januvia) (1 trial)
taurolidine (Defencath) (1 trial)
Bone Diseases (Phase 4)
Bone Diseases, Metabolic (Phase 4)
Liver Failure (Phase 4)
Short Bowel Syndrome (Phase 4)
Syndrome (Phase 4)
Trials (4 total)
Trial APIs (4 total)